COMPASS THERAPEUTICS INC (CMPX) Stock Balance Sheet
NASDAQ:CMPX - Nasdaq - US20454B1044 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 43.48M | 24.23M | 34.90M | 144.50M | 47.10M | |||
| Marketable Securities | 83.24M | 128.23M | 151.70M | N/A | N/A | |||
| Other Current Assets | 6.03M | 1.42M | 8.20M | 2.60M | 3.10M | |||
| Total Current Assets | 132.75M | 153.88M | 194.80M | 147.10M | 50.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.08M | 2.67M | 4.50M | 6.30M | 1.10M | |||
| Other Non-Current Assets | 568.00K | 320.00K | 300.00K | 300.00K | 600.00K | |||
| Total Non-Current Assets | 7.65M | 2.99M | 4.80M | 6.70M | 1.70M | |||
| TOTAL ASSETS | 140.40M | 156.88M | 199.60M | 153.80M | 51.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 7.50M | |||
| Accrued Expenses | 6.63M | 3.71M | 12.80M | 9.80M | 1.60M | |||
| Accounts Payable | 2.25M | 4.09M | 3.40M | 900.00K | 1.10M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 8.87M | 7.80M | 16.20M | 10.60M | 10.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.90M | |||
| Other Non-Current Liabilities | 6.30M | 536.00K | 1.80M | 3.00M | N/A | |||
| Total Non-Current Liabilities | 6.30M | 536.00K | 1.80M | 3.10M | 1.90M | |||
| TOTAL LIABILITIES | 15.17M | 8.34M | 18.00M | 13.70M | 12.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -364.68M | -315.31M | -272.80M | -233.60M | -151.40M | |||
| Additional Paid In Capital | 489.69M | 463.80M | 454.70M | 373.70M | 191.30M | |||
| Common Shares | 14.00K | 13.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 210.00K | 37.00K | -300.00K | N/A | N/A | |||
| Shares Outstanding | 137.82M | 127.67M | 126.30M | 101.30M | 51.20M | |||
| Tangible Book Value per Share | 0.91 | 1.16 | 1.44 | 1.38 | 0.78 | |||
| Total Shareholders' Equity | 125.23M | 148.54M | 181.60M | 140.10M | 39.90M | |||
| TOTAL LIABILITIES AND EQUITY | 140.40M | 156.88M | 199.60M | 153.80M | 51.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.05 | |||
| Current Ratio | 14.96 | 19.73 | 12.02 | 13.88 | 4.97 | |||
| Return On Assets (ROA) | -35.17% | -27.09% | -19.65% | -53.43% | -56.84% | |||
| Return On Equity (ROE) | -39.43% | -28.61% | -21.60% | -58.66% | -73.93% | |||
All data in USD , ROIC based on taxRate of 0.21